Michael Markey
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 10%
- Cancer-related Molecular Pathways
Papers in
-
- DNA Repair Mechanisms 4
- Epigenetics and DNA Methylation 4
- Ubiquitin and proteasome pathways 3
- Molecular Biology Techniques and Applications 3
- RNA modifications and cancer 3
- RNA Research and Splicing 2
- Melanoma and MAPK Pathways 2
- Oncology 12
- Cancer-related Molecular Pathways 11
- Co-authors
- Erik S. Knudsen (6 shared papers)Steven P. Angus (4 shared papers)Steven J. Berberich (3 shared papers)Bruce J. Aronow (2 shared papers)Sarah Williams (2 shared papers)Marjorie S. Morgan (1 shared paper)Ranjaka W. Gunawardena (1 shared paper)Larry G. Arlian (1 shared paper)
- Journals
- Oncogene (2 papers)International Journal of Molecular Sciences (2 papers)PLoS ONE (2 papers)Journal of Biological Chemistry (2 papers)Developmental Biology (1 paper)
- Partner nations
- United StatesGermany
In The Last Decade
Michael Markey
24 papers receiving 674 citations
Peers
Comparison fields: 5 of 81
- Cancer Research 137
- Oncology 246
- Molecular Biology 444
- Ophthalmology 47
- Cell Biology 63
Countries citing papers authored by Michael Markey
This map shows the geographic impact of Michael Markey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Markey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Markey more than expected).
Fields of papers citing papers by Michael Markey
This network shows the impact of papers produced by Michael Markey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Markey. The network helps show where Michael Markey may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Markey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Unbiased analysis of RB-mediated transcriptional repression identifies novel targets and distinctions from E2F action. | 2002 | 104 |
| 2 | 2012 | 78 | |
| 3 | 2002 | 77 | |
| 4 | 2007 | 66 | |
| 5 | 2013 | 46 | |
| 6 | 2006 | 39 | |
| 7 | 2011 | 37 | |
| 8 | 2004 | 37 | |
| 9 | 2002 | 34 | |
| 10 | 2008 | 28 | |
| 11 | 2004 | 20 | |
| 12 | Enhancing the efficacy of AREDS antioxidants in light-induced retinal degeneration. | 2017 | 19 |
| 13 | 2015 | 18 | |
| 14 | 2009 | 17 | |
| 15 | 2017 | 13 | |
| 16 | 2016 | 13 | |
| 17 | 2018 | 12 | |
| 18 | 2023 | 9 | |
| 19 | 2021 | 5 | |
| 20 | 2017 | 5 |
About Michael Markey
Michael Markey is a scholar working on Molecular Biology, Oncology, Cancer Research, Infectious Diseases and Ophthalmology, having authored 24 papers that have together received 684 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (11 papers), DNA Repair Mechanisms (4 papers), Epigenetics and DNA Methylation (4 papers), Ubiquitin and proteasome pathways (3 papers), Molecular Biology Techniques and Applications (3 papers), RNA modifications and cancer (3 papers), RNA Research and Splicing (2 papers) and Melanoma and MAPK Pathways (2 papers). The work is most often cited by research in Cancer Research (137 citations), Oncology (246 citations), Molecular Biology (444 citations), Ophthalmology (47 citations) and Cell Biology (63 citations). Michael Markey has collaborated with scholars based in United States and Germany. Frequent co-authors include Erik S. Knudsen, Steven P. Angus, Steven J. Berberich, Bruce J. Aronow, Sarah Williams, Marjorie S. Morgan, Ranjaka W. Gunawardena, Larry G. Arlian, Matthew W. Strobeck and Benjamin R. Bates. Their work appears in journals such as Oncogene, International Journal of Molecular Sciences, PLoS ONE, Journal of Biological Chemistry and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.